LFM-A13
62004-35-7
98%
2026-07-25
Coenzymes,Inhibito,Enzymes,Zymogens,Substrates,Native Microorganism Creatine Amidinohydrolase
-
Product Description
-
Seller Information
-
Description
ProductName LFM-A13 Cat No CEI-0966 Description Potent and selective inhibitor of Bruton's tyrosine kinase (BTK). Inhibits recombinant BTK with an IC50 = 2.5 uM and has no activity at other protein kinases (including JAK1, JAK3, HCK, EGFR kinase and insulin receptor kinase) at concentrations up to 300 uM. Abbr LFM-A13(BTK) Alias 2-Cyano-N-(2, 5-dibromophenyl)-3-hydroxy-2-butenamide Appearance Yellow powder Product Overview BTK Inhibitor CAS No 62004-35-7 Molecular Weight 360 Purity 98% (TLC: 2:8 CH3OH:CH2Cl2; Rf=0.53); NMR (Conforms) Synonyms 2-Cyano-N-(2,5-dibromophenyl)-3-hydroxy-2-butenamide Targets BTK Molecular Formula C11H8Br2N2O2 Melting Point 145-146ºC Solubility DMSO (10 mg/ml) and ethanol (15 mg/ml) category Specialty Chemicals(c26) cas_num 62004-35-7 Basic Info-
Product Name:
LFM-A13
CAS No.:62004-35-7
Categories:
-
-
Seller Information
-
Business Type:
Manufactory
-
Main Products:
Coenzymes,Inhibito,Enzymes,Zymogens,Substrates,Native Microorganism Creatine Amidinohydrolase
-
Location:
Shirley, New York 11967, USA
-
Payment Terms:
TT against copy of documents,D/P
-
Average lead Time:
15
-
Total Annual Revenue:
$1 million-$2.5 million
-
Year of Establishment:
2004
-
-
Country Product Purchase Quantity Date Posted Post an enquiry for this product